Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity.

Tan YK, Li H, Allen JC, Thumboo J. Anti-cyclic citrullinated peptide but not rheumatoid factor is associated with ultrasound-detected bone erosion among rheumatoid arthritis patients with at least moderate disease activity. Int J Rheum Dis. 2020 Oct; 23(10):1337-1343.

View in: PubMed

subject areas

Aged
Arthritis, Rheumatoid
Cross-Sectional Studies
Female
Humans
Joints
Male
Middle Aged
Peptides, Cyclic
Predictive Value of Tests
Rheumatoid Factor
Severity of Illness Index
Ultrasonography, Doppler

authors with profiles

John S. Allen, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support